<div class="welcome-screen" id="welcomeScreen">
    <div class="welcome-banner">
        <h1 id="welcome-title">Welcome to the page on inflammatory dermatoses!</h1>
        <p id="welcome-description">Explore the following the main aetiologies here (with pictures!).</p>
    </div>
    
    <div class="explanation-card">
        <h1>Introduction to Inflammatory Dermatoses</h1>
        
        <h2>Anatomy of the Skin Relevant to Inflammation</h2>
        <p>The skin is composed of three primary layers: the <b>epidermis</b>, <b>dermis</b>, and <b>subcutaneous tissue</b>. The epidermis itself is stratified into several layers (from deep to superficial): stratum basale, stratum spinosum, stratum granulosum, stratum lucidum (only in thick skin), and stratum corneum. The dermis contains blood vessels, nerves, appendages, and immune cells that play crucial roles in inflammatory processes.</p>
        
        <p>The skin hosts a complex <b>immune surveillance system</b> including Langerhans cells (antigen-presenting cells in the epidermis), dermal dendritic cells, mast cells, and tissue-resident memory T cells. These components form the <b>skin immune system (SIS)</b>, which maintains homeostasis and responds to threats.</p>
        
        <h2>Physiology of Cutaneous Inflammation</h2>
        <p>Inflammation is the skin's response to injury, infection, or immune dysregulation. The process involves <b>vascular changes</b> (vasodilation, increased permeability), <b>cellular recruitment</b> (leukocyte migration), and <b>mediator release</b> (cytokines, chemokines, prostaglandins).</p>
        
        <p>The inflammatory cascade can be initiated through multiple pathways:</p>
        <ol>
            <li><b>Innate immune activation</b> via pattern recognition receptors (e.g., TLRs)</li>
            <li><b>Adaptive immune responses</b> mediated by T cells and antibodies</li>
            <li><b>Direct tissue damage</b> triggering danger signals</li>
        </ol>
        
        <h2>Histopathology of Inflammatory Dermatoses</h2>
        <p>Microscopic examination reveals characteristic patterns:</p>
        <ol>
            <li><b>Spongiotic dermatitis</b>: Intercellular edema in the epidermis (e.g., eczema)</li>
            <li><b>Psoriasiform dermatitis</b>: Regular epidermal hyperplasia with elongated rete ridges</li>
            <li><b>Interface dermatitis</b>: Lymphocytic infiltration at the dermoepidermal junction</li>
            <li><b>Vasculitis</b>: Inflammation and damage to blood vessel walls</li>
        </ol>
        
        <div class="mnemonic">
            <b>Mnemonic: "SPIV" for Inflammatory Patterns</b><br>
            <b>S</b>pongiotic - <b>P</b>soriasiform - <b>I</b>nterface - <b>V</b>asculitis
        </div>
    </div>
    
    <div class="question-card">
        <h1>Question 1</h1>
        <p>Which of the following is NOT a primary layer of the skin?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Epidermis</li>
            <li data-answer="wrong">Dermis</li>
            <li data-answer="correct">Stratum corneum</li>
            <li data-answer="wrong">Subcutaneous tissue</li>
        </ul>
    </div>
    
    <div class="question-card">
        <h1>Question 2</h1>
        <p>Which inflammatory pattern is characterized by intercellular edema in the epidermis?</p>
        <ul class="options" id="options">
            <li data-answer="correct">Spongiotic dermatitis</li>
            <li data-answer="wrong">Psoriasiform dermatitis</li>
            <li data-answer="wrong">Interface dermatitis</li>
            <li data-answer="wrong">Vasculitis</li>
        </ul>
    </div>
    
    <div class="explanation-card">
        <h1>Overview and Diagnostic Approach to Inflammatory Dermatoses</h1>
        
        <p>Inflammatory dermatoses present with a variety of morphologies including <b>erythema</b>, <b>scaling</b>, <b>papules</b>, <b>plaques</b>, and <b>vesicles</b>. The diagnostic approach involves:</p>
        
        <ol>
            <li><b>Morphology</b>: Primary and secondary lesions</li>
            <li><b>Distribution</b>: Pattern of involvement (flexural, extensor, photodistributed, etc.)</li>
            <li><b>Time course</b>: Acute, chronic, or relapsing</li>
            <li><b>Associated symptoms</b>: Pruritus, pain, systemic manifestations</li>
        </ol>
        
        <h2>Key Differential Diagnostic Features</h2>
        <p>Several clinical clues help distinguish between common inflammatory dermatoses:</p>
        
        <p><b>Scale characteristics</b>:</p>
        <ol>
            <li><b>Psoriasis</b>: Thick, silvery-white, adherent scale</li>
            <li><b>Eczema</b>: Fine, white, loose scale</li>
            <li><b>Seborrheic dermatitis</b>: Greasy, yellowish scale</li>
        </ol>
        
        <p><b>Border characteristics</b>:</p>
        <ol>
            <li><b>Psoriasis</b>: Well-demarcated borders</li>
            <li><b>Nummular eczema</b>: Less distinct borders</li>
            <li><b>Tinea corporis</b>: Active, advancing scaly border</li>
        </ol>
        
        <div class="mnemonic">
            <b>Mnemonic: "PETS" for Scaly Dermatoses</b><br>
            <b>P</b>soriasis - <b>E</b>czema - <b>T</b>inea - <b>S</b>eborrheic dermatitis
        </div>
    </div>
    
    <div class="question-card">
        <h1>Question 3</h1>
        <p>A patient presents with thick, silvery-white scales on well-demarcated erythematous plaques. What is the most likely diagnosis?</p>
        <ul class="options" id="options">
            <li data-answer="correct">Psoriasis</li>
            <li data-answer="wrong">Atopic dermatitis</li>
            <li data-answer="wrong">Tinea corporis</li>
            <li data-answer="wrong">Pityriasis rosea</li>
        </ul>
    </div>
    
    <div class="question-card">
        <h1>Question 4</h1>
        <p>Which of the following is NOT typically a feature of eczema?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Pruritus</li>
            <li data-answer="wrong">Fine white scale</li>
            <li data-answer="correct">Well-demarcated borders</li>
            <li data-answer="wrong">Lichenification in chronic cases</li>
        </ul>
    </div>
    
    <div class="explanation-card">
        <h1>Psoriasis</h1>
        
        <h2>Introduction</h2>
        <p>Psoriasis is a <b>chronic, immune-mediated</b> inflammatory skin disorder characterized by <b>hyperproliferation of keratinocytes</b> and <b>dermal inflammation</b>. It affects approximately 2-3% of the population worldwide and has significant impact on quality of life.</p>
        
        <h2>Signs and Symptoms</h2>
        <p>The classic presentation includes:</p>
        <ol>
            <li><b>Plaque psoriasis</b> (most common): Well-demarcated, erythematous plaques with adherent silvery scale, typically on extensor surfaces (elbows, knees), scalp, and lumbosacral area</li>
            <li><b>Ausspitz sign</b>: Pinpoint bleeding when scale is removed (due to elongated dermal papillae)</li>
            <li><b>Koebner phenomenon</b>: Lesions developing at sites of trauma</li>
            <li><b>Nail changes</b>: Pitting, oil spots, onycholysis, subungual hyperkeratosis</li>
        </ol>
        
        <h2>Aetiology and Pathophysiology</h2>
        <p>Psoriasis results from complex interactions between <b>genetic predisposition</b> (PSORS loci, HLA-Cw6) and <b>environmental triggers</b> (stress, infection, medications). The pathophysiology involves:</p>
        <ol>
            <li><b>T cell activation</b>: Particularly Th1, Th17, and Th22 subsets</li>
            <li><b>Cytokine release</b>: TNF-α, IL-17, IL-22, IL-23</li>
            <li><b>Keratinocyte proliferation</b>: Cell cycle shortened from 28 to 3-5 days</li>
        </ol>
        
        <h2>Diagnosis</h2>
        <p>Diagnosis is primarily clinical. Biopsy shows:</p>
        <ol>
            <li><b>Regular epidermal hyperplasia</b> (psoriasiform pattern)</li>
            <li><b>Parakeratosis</b> (nuclei retained in stratum corneum)</li>
            <li><b>Munro microabscesses</b> (neutrophils in stratum corneum)</li>
            <li><b>Dilated capillaries</b> in dermal papillae</li>
        </ol>
        
        <h2>Treatment</h2>
        <p>Treatment depends on disease severity:</p>
        <ol>
            <li><b>Topical therapy</b>: Corticosteroids, vitamin D analogs, retinoids</li>
            <li><b>Phototherapy</b>: Narrowband UVB, PUVA</li>
            <li><b>Systemic therapy</b>: Methotrexate, cyclosporine, acitretin</li>
            <li><b>Biologics</b>: TNF-α inhibitors, IL-17/23 inhibitors</li>
        </ol>
        
        <h2>Prognosis and Complications</h2>
        <p>Psoriasis is chronic with periods of exacerbation and remission. Associated comorbidities include:</p>
        <ol>
            <li><b>Psoriatic arthritis</b> (in 30% of patients)</li>
            <li><b>Cardiovascular disease</b></li>
            <li><b>Metabolic syndrome</b></li>
            <li><b>Psychosocial impact</b></li>
        </ol>
        
        <div class="mnemonic">
            <b>Mnemonic: "KIND Psoriasis" for Histologic Features</b><br>
            <b>K</b>eratinocyte proliferation - <b>I</b>nflammation - <b>N</b>eutrophils (microabscesses) - <b>D</b>ilated capillaries
        </div>
    </div>
    
    <div class="question-card">
        <h1>Question 5</h1>
        <p>Which cytokine is NOT typically elevated in psoriasis?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">IL-17</li>
            <li data-answer="wrong">TNF-α</li>
            <li data-answer="correct">IL-4</li>
            <li data-answer="wrong">IL-23</li>
        </ul>
    </div>
    
    <div class="question-card">
        <h1>Question 6</h1>
        <p>A patient with plaque psoriasis develops joint pain and swelling. What is the most likely complication?</p>
        <ul class="options" id="options">
            <li data-answer="correct">Psoriatic arthritis</li>
            <li data-answer="wrong">Rheumatoid arthritis</li>
            <li data-answer="wrong">Gout</li>
            <li data-answer="wrong">Osteoarthritis</li>
        </ul>
    </div>
    
    <div class="explanation-card">
        <h1>Atopic Dermatitis (Eczema)</h1>
        
        <h2>Introduction</h2>
        <p>Atopic dermatitis is a <b>chronic, pruritic, inflammatory</b> skin condition characterized by <b>impaired skin barrier function</b> and <b>immune dysregulation</b>. It is the most common inflammatory skin disease, affecting up to 20% of children and 3% of adults.</p>
        
        <h2>Signs and Symptoms</h2>
        <p>Clinical features vary by age:</p>
        <ol>
            <li><b>Infantile phase</b> (0-2 years): Erythematous, oozing, crusted plaques on cheeks and extensor surfaces</li>
            <li><b>Childhood phase</b> (2-12 years): Flexural lichenified plaques (antecubital/popliteal fossae, neck)</li>
            <li><b>Adult phase</b>: Chronic lichenified plaques with excoriations, often widespread</li>
        </ol>
        
        <p>Associated features include:</p>
        <ol>
            <li><b>Xerosis</b> (dry skin)</li>
            <li><b>Pruritus</b> (often severe, "the itch that rashes")</li>
            <li><b>Atopic stigmata</b>: Dennie-Morgan folds (infraorbital folds), hyperlinear palms, keratosis pilaris</li>
        </ol>
        
        <h2>Aetiology and Pathophysiology</h2>
        <p>Atopic dermatitis results from complex interactions between:</p>
        <ol>
            <li><b>Genetic factors</b>: Filaggrin mutations (FLG), other epidermal barrier genes</li>
            <li><b>Immune dysregulation</b>: Th2 skewing with elevated IL-4, IL-5, IL-13, IL-31</li>
            <li><b>Environmental triggers</b>: Irritants, allergens, microbes (S. aureus), stress</li>
        </ol>
        
        <h2>Diagnosis</h2>
        <p>Diagnosis is clinical based on Hanifin and Rajka criteria (requires 3 of 4 major criteria and ≥3 minor criteria). Biopsy shows:</p>
        <ol>
            <li><b>Spongiosis</b> (intercellular edema)</li>
            <li><b>Lymphocytic infiltrate</b></li>
            <li><b>Hyperkeratosis</b> and <b>parakeratosis</b> in chronic lesions</li>
        </ol>
        
        <h2>Treatment</h2>
        <p>Management involves:</p>
        <ol>
            <li><b>Skin barrier repair</b>: Emollients, gentle cleansers</li>
            <li><b>Topical anti-inflammatory</b>: Corticosteroids, calcineurin inhibitors (tacrolimus, pimecrolimus)</li>
            <li><b>Systemic therapy</b>: Dupilumab (IL-4/13 inhibitor), cyclosporine, methotrexate</li>
            <li><b>Trigger avoidance</b>: Irritants, allergens, stress management</li>
        </ol>
        
        <h2>Prognosis and Complications</h2>
        <p>Course is chronic with flares. Complications include:</p>
        <ol>
            <li><b>Skin infections</b>: Impetigo, eczema herpeticum</li>
            <li><b>Sleep disturbance</b> from pruritus</li>
            <li><b>Atopic march</b>: Progression to asthma/allergic rhinitis</li>
        </ol>
        
        <div class="mnemonic">
            <b>Mnemonic: "ITCH" for Atopic Dermatitis Features</b><br>
            <b>I</b>nflammation - <b>T</b>h2 cytokines - <b>C</b>hronic pruritus - <b>H</b>yperlinear palms
        </div>
    </div>
    
    <div class="question-card">
        <h1>Question 7</h1>
        <p>Which genetic mutation is most strongly associated with atopic dermatitis?</p>
        <ul class="options" id="options">
            <li data-answer="correct">Filaggrin (FLG)</li>
            <li data-answer="wrong">BRCA1</li>
            <li data-answer="wrong">CFTR</li>
            <li data-answer="wrong">COL7A1</li>
        </ul>
    </div>
    
    <div class="question-card">
        <h1>Question 8</h1>
        <p>A 4-year-old child with atopic dermatitis develops grouped vesicles with punched-out erosions. What is the most likely complication?</p>
        <ul class="options" id="options">
            <li data-answer="correct">Eczema herpeticum</li>
            <li data-answer="wrong">Impetigo</li>
            <li data-answer="wrong">Scabies</li>
            <li data-answer="wrong">Contact dermatitis</li>
        </ul>
    </div>

    <div class="explanation-card">
        <h1>Contact Dermatitis</h1>
        
        <h2>Introduction</h2>
        <p>Contact dermatitis is an inflammatory skin reaction to <b>exogenous substances</b> that may occur through <b>irritant</b> or <b>allergic</b> mechanisms. It accounts for approximately 80% of occupational skin diseases and affects 15-20% of the general population at some point in their lives.</p>
        
        <h2>Signs and Symptoms</h2>
        <p>Clinical presentation varies by type:</p>
        <ol>
            <li><b>Irritant contact dermatitis</b>:
                <ol>
                    <li>Erythema, edema, vesicles (acute) or dryness, fissuring (chronic)</li>
                    <li>Sharp borders corresponding to area of exposure</li>
                    <li>Burning/stinging more than pruritus</li>
                </ol>
            </li>
            <li><b>Allergic contact dermatitis</b>:
                <ol>
                    <li>Pruritic erythema, papules, vesicles with indistinct borders</li>
                    <li>Delayed onset (24-72 hours post-exposure)</li>
                    <li>May spread beyond contact area (autoeczematization)</li>
                </ol>
            </li>
        </ol>
        
        <h2>Aetiology and Pathophysiology</h2>
        <p><b>Irritant contact dermatitis</b> (80% of cases):</p>
        <ol>
            <li>Direct cytotoxic damage to keratinocytes</li>
            <li>No prior sensitization required</li>
            <li>Common irritants: Detergents, solvents, acids/alkalis</li>
        </ol>
        
        <p><b>Allergic contact dermatitis</b> (Type IV hypersensitivity):</p>
        <ol>
            <li>Sensitization phase (10-14 days after first exposure)</li>
            <li>Elicitation phase (24-72 hours after re-exposure)</li>
            <li>Common allergens: Nickel, fragrance mix, balsam of Peru, paraphenylenediamine</li>
        </ol>
        
        <h2>Diagnosis</h2>
        <p>Diagnostic approach includes:</p>
        <ol>
            <li><b>Clinical history</b>: Exposure patterns, temporal relationship</li>
            <li><b>Physical examination</b>: Distribution often suggests causative agent</li>
            <li><b>Patch testing</b> (for allergic type): Application of common allergens to back for 48 hours, read at 96 hours</li>
        </ol>
        
        <h2>Treatment</h2>
        <p>Management strategies:</p>
        <ol>
            <li><b>Avoidance</b>: Identify and eliminate causative agent</li>
            <li><b>Topical therapy</b>: Corticosteroids, calcineurin inhibitors</li>
            <li><b>Systemic therapy</b>: Oral corticosteroids for severe cases</li>
            <li><b>Barrier protection</b>: Gloves, emollients</li>
        </ol>
        
        <div class="mnemonic">
            <b>Mnemonic: "CONTACT" for Common Allergens</b><br>
            <b>C</b>obalt - <b>O</b>ils (plants) - <b>N</b>ickel - <b>T</b>himerosal - <b>A</b>crylates - <b>C</b>hromates - <b>T</b>opical antibiotics (neomycin)
        </div>
    </div>
    
    <div class="question-card">
        <h1>Question 9</h1>
        <p>A hairdresser presents with erythema and scaling on the dorsal hands and fingers. What is the most likely causative allergen?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Nickel</li>
            <li data-answer="correct">Paraphenylenediamine</li>
            <li data-answer="wrong">Fragrance mix</li>
            <li data-answer="wrong">Balsam of Peru</li>
        </ul>
    </div>
    
    <div class="question-card">
        <h1>Question 10</h1>
        <p>Which statement is TRUE about irritant contact dermatitis compared to allergic contact dermatitis?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Requires prior sensitization</li>
            <li data-answer="correct">More likely to cause burning than itching</li>
            <li data-answer="wrong">Typically has indistinct borders</li>
            <li data-answer="wrong">Shows positive patch testing</li>
        </ul>
    </div>
    
    <div class="explanation-card">
        <h1>Lichen Planus</h1>
        
        <h2>Introduction</h2>
        <p>Lichen planus is a <b>T cell-mediated</b> inflammatory disorder affecting skin and mucous membranes, characterized by <b>pruritic, purple, polygonal papules</b>. It has a worldwide prevalence of 0.5-1% and typically affects adults aged 30-60 years.</p>
        
        <h2>Signs and Symptoms</h2>
        <p>Clinical features include:</p>
        <ol>
            <li><b>Cutaneous lesions</b>:
                <ol>
                    <li>Violaceous, flat-topped papules with fine white lines (Wickham striae)</li>
                    <li>Preferred locations: Flexor wrists, ankles, oral mucosa</li>
                    <li>Koebner phenomenon present</li>
                </ol>
            </li>
            <li><b>Mucosal involvement</b> (in 50% of cases):
                <ol>
                    <li>Reticular white streaks on buccal mucosa</li>
                    <li>Painful erosions may occur</li>
                </ol>
            </li>
            <li><b>Variants</b>: Hypertrophic, follicular, actinic, vesiculobullous</li>
        </ol>
        
        <h2>Aetiology and Pathophysiology</h2>
        <p>The exact cause remains unknown but involves:</p>
        <ol>
            <li><b>Autoimmune process</b>: CD8+ T cells attack basal keratinocytes</li>
            <li><b>Genetic predisposition</b>: Association with HLA-DR1, DR10</li>
            <li><b>Triggers</b>: Hepatitis C infection, certain drugs (β-blockers, NSAIDs), dental metals</li>
        </ol>
        
        <h2>Diagnosis</h2>
        <p>Diagnostic methods:</p>
        <ol>
            <li><b>Clinical examination</b>: Characteristic morphology and distribution</li>
            <li><b>Biopsy findings</b>:
                <ol>
                    <li>Hyperkeratosis without parakeratosis</li>
                    <li>Saw-tooth rete ridges</li>
                    <li>Liquefaction degeneration of basal layer</li>
                    <li>Band-like lymphocytic infiltrate at dermoepidermal junction</li>
                </ol>
            </li>
        </ol>
        
        <h2>Treatment</h2>
        <p>Management options:</p>
        <ol>
            <li><b>Topical therapy</b>: High-potency corticosteroids, tacrolimus (for mucosal lesions)</li>
            <li><b>Systemic therapy</b>: Oral corticosteroids, retinoids, methotrexate</li>
            <li><b>Phototherapy</b>: Narrowband UVB</li>
            <li><b>Monitoring</b>: Oral lesions require cancer surveillance (1% risk of SCC)</li>
        </ol>
        
        <div class="mnemonic">
            <b>Mnemonic: "5 P's of Lichen Planus"</b><br>
            <b>P</b>ruritic - <b>P</b>urple - <b>P</b>olygonal - <b>P</b>apules - <b>P</b>laques
        </div>
    </div>
    
    <div class="question-card">
        <h1>Question 11</h1>
        <p>Which histologic feature is pathognomonic for lichen planus?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Munro microabscesses</li>
            <li data-answer="wrong">Spongiosis</li>
            <li data-answer="correct">Liquefaction degeneration of basal layer</li>
            <li data-answer="wrong">Palisading granulomas</li>
        </ul>
    </div>
    
    <div class="question-card">
        <h1>Question 12</h1>
        <p>A patient presents with white reticulated streaks on the buccal mucosa. What is the most likely diagnosis?</p>
        <ul class="options" id="options">
            <li data-answer="correct">Oral lichen planus</li>
            <li data-answer="wrong">Leukoplakia</li>
            <li data-answer="wrong">Oral candidiasis</li>
            <li data-answer="wrong">Aphthous stomatitis</li>
        </ul>
    </div>
    
    <div class="explanation-card">
        <h1>Seborrheic Dermatitis</h1>
        
        <h2>Introduction</h2>
        <p>Seborrheic dermatitis is a <b>chronic, relapsing</b> inflammatory dermatosis characterized by <b>erythema and greasy scales</b> in sebum-rich areas. It affects 3-5% of the population, with two peaks of incidence: infancy (cradle cap) and adulthood (ages 30-60).</p>
        
        <h2>Signs and Symptoms</h2>
        <p>Clinical presentation includes:</p>
        <ol>
            <li><b>Distribution</b>:
                <ol>
                    <li>Scalp (dandruff), eyebrows, nasolabial folds</li>
                    <li>Postauricular area, presternal area</li>
                    <li>Beard area in men</li>
                </ol>
            </li>
            <li><b>Lesion characteristics</b>:
                <ol>
                    <li>Erythematous patches or thin plaques</li>
                    <li>Yellowish, greasy scales</li>
                    <li>Mild pruritus common</li>
                </ol>
            </li>
        </ol>
        
        <h2>Aetiology and Pathophysiology</h2>
        <p>The pathogenesis involves three key factors:</p>
        <ol>
            <li><b>Malassezia yeast</b> (M. globosa, M. restricta): Lipase production leads to inflammatory free fatty acids</li>
            <li><b>Sebum production</b>: Androgen-mediated, explains distribution</li>
            <li><b>Immune response</b>: Both innate and adaptive immunity contribute</li>
        </ol>
        
        <p>Predisposing factors include:</p>
        <ol>
            <li>Parkinson's disease</li>
            <li>HIV infection (often severe and refractory)</li>
            <li>Certain medications (e.g., psoralen, lithium)</li>
        </ol>
        
        <h2>Diagnosis</h2>
        <p>Diagnosis is clinical based on:</p>
        <ol>
            <li>Characteristic distribution and morphology</li>
            <li>Response to antifungal/anti-inflammatory treatment</li>
            <li>KOH preparation may show yeast forms (but not required)</li>
        </ol>
        
        <h2>Treatment</h2>
        <p>Management approaches:</p>
        <ol>
            <li><b>Topical antifungals</b>: Ketoconazole, ciclopirox (shampoos, creams)</li>
            <li><b>Low-potency steroids</b>: Hydrocortisone 1% for facial lesions</li>
            <li><b>Calcineurin inhibitors</b>: Tacrolimus, pimecrolimus for maintenance</li>
            <li><b>Keratinolytics</b>: Salicylic acid, coal tar for scalp scaling</li>
        </ol>
        
        <div class="mnemonic">
            <b>Mnemonic: "SCALP" for Seborrheic Dermatitis Features</b><br>
            <b>S</b>ebum-rich areas - <b>C</b>hronic course - <b>A</b>ntifungal responsive - <b>L</b>ow-potency steroids - <b>P</b>ruritus mild
        </div>
    </div>
    
    <div class="question-card">
        <h1>Question 13</h1>
        <p>Which organism is most implicated in the pathogenesis of seborrheic dermatitis?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Staphylococcus aureus</li>
            <li data-answer="correct">Malassezia spp.</li>
            <li data-answer="wrong">Candida albicans</li>
            <li data-answer="wrong">Demodex folliculorum</li>
        </ul>
    </div>
    
    <div class="question-card">
        <h1>Question 14</h1>
        <p>A patient with HIV presents with severe erythema and thick, greasy scales involving the entire face and chest. What is the most likely diagnosis?</p>
        <ul class="options" id="options">
            <li data-answer="correct">Seborrheic dermatitis</li>
            <li data-answer="wrong">Psoriasis</li>
            <li data-answer="wrong">Rosacea</li>
            <li data-answer="wrong">Systemic lupus erythematosus</li>
        </ul>
    </div>
    
    <div class="explanation-card">
        <h1>Pityriasis Rosea</h1>
        
        <h2>Introduction</h2>
        <p>Pityriasis rosea is an <b>acute, self-limited</b> inflammatory dermatosis characterized by <b>oval, scaly plaques</b> following the cleavage lines of the skin. It primarily affects adolescents and young adults (ages 10-35), with a slight female predominance.</p>
        
        <h2>Signs and Symptoms</h2>
        <p>The classic presentation includes:</p>
        <ol>
            <li><b>Herald patch</b> (50-90% of cases):
                <ol>
                    <li>Single 2-10 cm oval plaque with central clearing</li>
                    <li>Appears 1-2 weeks before generalized eruption</li>
                    <li>Often on trunk, neck, or proximal extremities</li>
                </ol>
            </li>
            <li><b>Secondary eruption</b>:
                <ol>
                    <li>Multiple 0.5-2 cm oval papules/plaques</li>
                    <li>"Christmas tree" distribution on back (following Langer lines)</li>
                    <li>Collarette scale (peripheral scaling with central clearance)</li>
                </ol>
            </li>
            <li><b>Mild pruritus</b> (25% of cases)</li>
        </ol>
        
        <h2>Aetiology and Pathophysiology</h2>
        <p>While the exact cause remains uncertain, evidence suggests:</p>
        <ol>
            <li><b>Viral trigger</b>: Associated with human herpesviruses 6/7 (HHV-6/7)</li>
            <li><b>Seasonal variation</b>: More common in spring and fall</li>
            <li><b>Immune-mediated</b>: Likely a host response to viral antigens</li>
        </ol>
        
        <h2>Diagnosis</h2>
        <p>Diagnosis is primarily clinical. Differential diagnosis includes:</p>
        <ol>
            <li>Tinea corporis (KOH preparation negative in pityriasis rosea)</li>
            <li>Secondary syphilis (RPR/VDRL negative in pityriasis rosea)</li>
            <li>Guttate psoriasis (more scaly, no herald patch)</li>
        </ol>
        
        <h2>Treatment</h2>
        <p>As a self-limiting condition (resolves in 6-12 weeks), treatment focuses on symptom relief:</p>
        <ol>
            <li><b>Emollients</b>: For dry skin</li>
            <li><b>Topical steroids</b>: For pruritus</li>
            <li><b>Phototherapy</b>: UVB may hasten resolution</li>
            <li><b>Antivirals</b>: Acyclovir may be beneficial if started early</li>
        </ol>
        
        <div class="mnemonic">
            <b>Mnemonic: "ROSEA" for Pityriasis Rosea Features</b><br>
            <b>R</b>ecent viral illness - <b>O</b>val plaques - <b>S</b>easonal - <b>E</b>vanescent (self-limiting) - <b>A</b>dolescents affected
        </div>
    </div>
    
    <div class="question-card">
        <h1>Question 15</h1>
        <p>What is the characteristic distribution pattern of pityriasis rosea on the back?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Dermatomal</li>
            <li data-answer="wrong">Reticulated</li>
            <li data-answer="correct">Christmas tree pattern</li>
            <li data-answer="wrong">Annular</li>
        </ul>
    </div>
    
    <div class="question-card">
        <h1>Question 16</h1>
        <p>A 22-year-old woman develops a single 3 cm oval plaque on her abdomen, followed two weeks later by numerous smaller similar lesions on her trunk. What is the most likely diagnosis?</p>
        <ul class="options" id="options">
            <li data-answer="correct">Pityriasis rosea</li>
            <li data-answer="wrong">Tinea corporis</li>
            <li data-answer="wrong">Lichen planus</li>
            <li data-answer="wrong">Nummular eczema</li>
        </ul>
    </div>

    <div class="placeholder" id="empty">Test</div>

</div>